De novo lipogenesis and inflammation are two of the major elements involved in the development of NAFLD in humans underlying the potential relevance of disturbed SOD function the accompanying metabolic disturbances [31,32]. Here, SOD1 is linked to metabolic dysfunction-associated steatotic liver disease.